Table 1 Patient characteristics by treatment

From: Surgery and adjuvant radiotherapy vs concurrent chemoradiotherapy in stage III/IV nonmetastatic squamous cell head and neck cancer: a randomised comparison

 

C ( n =59)

S ( n =60)

All patients ( n =119)

Age (years)

   

 Median

60

58

59

 Range

35–73

27–75

27–75

Sex (%)

   

 Male

51 (86)

53 (88)

104 (87)

 Female

8 (14)

7 (12)

15 (13)

Race (%)

   

 Chinese

45 (76)

50 (84)

95 (80)

 Indian

8 (14)

5 (8)

13 (11)

 Malay

6 (10)

5 (8)

11 (9)

Site of disease (%)

   

 Oral cavity

19 (32)

13 (22)

32 (27)

 Oropharynx

12 (20)

13 (22)

25 (21)

 Hypopharynx

7 (12)

7 (12)

14 (12)

 Supraglottis

13 (22)

14 (23)

27 (23)

 Glottis

5 (9)

5 (8)

10 (8)

 Subglottis

0 (0)

1 (1)

1 (1)

 Maxillary sinus

3 (5)

7 (12)

10 (8)

Tumour status (%)

   

 T1

0 (0)

5 (8)

5 (4)

 T2

9 (15)

8 (13)

17 (14)

 T3

16 (27)

15 (25)

31 (26)

 T4

34 (58)

32 (54)

66 (56)

Nodal status (%)

   

 N0

19 (32)

17 (28)

36 (30)

 N1

15 (25)

7 (12)

22 (19)

 N2

24 (41)

31 (52)

55 (46)

 N3

1 (2)

5 (8)

6 (5)

TNM staging (%)

   

 Stage III

12 (20)

12 (20)

24 (20)

 Stage IVA

46 (78)

43 (72)

89 (75)

 Stage IVB

1 (2)

5 (8)

6 (5)